ASCLEPIX THERAPEUTICS
Live / Registered — Registered (as of 02 Jul 2024)
What this means for you
Registered since 02 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88944666
- Registration number
- 7434276
- Mark type
- Stylized text
- Filed
- 02 Jun 2020
- Published for opposition
- 09 Mar 2021
- Registered
- 02 Jul 2024
- Attorney of record
- Rachelle A. Dubow
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceutical for the treatment of retinal diseases; ocular pharmaceuticals
Owner
- AsclepiX Therapeutics, Inc., Bethesda, MD, US
- AsclepiX Therapeutics, Inc., Bethesda, MD, US
- AsclepiX Therapeutics, Inc., Jersey City, NJ, US
Prosecution history
- 02 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 28 May 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 May 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 May 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 01 May 2024 — USE AMENDMENT FILED
- 01 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 12 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Oct 2023 — SOU EXTENSION 5 GRANTED
- 02 Oct 2023 — SOU EXTENSION 5 FILED
- 11 Oct 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Apr 2023 — SOU EXTENSION 4 GRANTED
- 27 Apr 2023 — SOU EXTENSION 4 FILED